PUBLISHER: IMARC | PRODUCT CODE: 1519813
PUBLISHER: IMARC | PRODUCT CODE: 1519813
The global blood glucose test strips market size reached US$ 12.5 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 23.7 Billion by 2032, exhibiting a growth rate (CAGR) of 7.2% during 2024-2032.
Blood glucose test strips refer to small, disposable plastic or paper strips used to monitor blood glucose levels and control diabetes symptoms. They are manufactured using polyolefin, polyamide, polysulfone and cellulose materials. A blood glucose test strip comprises several components, such as hydrophilic, adhesive, sensors, enzymes and electrode layers. They are also soaked in glucose oxidase that reacts with glucose present in the blood sample to indicate sugar levels. Apart from this, blood glucose test strips are easy to use, cost-effective, and can be used daily. Consequently, they assist in identifying high or low blood sugar levels, monitoring the effectiveness of diabetes treatment, and lowering the risks of developing hypoglycemia and/or hyperglycemia.
The increasing prevalence of diabetes, especially among the growing geriatric population is creating a positive outlook for the market. In line with this, blood glucose test strips are widely used to test sugar levels regularly at home, while eliminating the need to visit a diagnostic laboratory, which is supporting the market growth. Additionally, the widespread product adoption among type-2 diabetic patients due to the easy availability of glucometers, convenient handling, and the level of accuracy provided by the machine are favoring the market growth. Moreover, the demand and online sales for blood glucose monitoring devices and consumables, such as test strips significantly surged during the coronavirus disease (COVID-19) pandemic. This can be attributed to the increasing need to continuously monitor sugar levels in patients and commoners both as a precautionary measure and to record post-infection symptoms, which, in turn, is augmenting the market growth. Other factors, including extensive research and development (R&D) activities in the field of biomedical engineering, evolving lifestyles and eating habits, and the implementation of various government initiatives focusing on educating the masses regarding diabetes and its preventive measures, are anticipated to drive the market toward growth.
IMARC Group provides an analysis of the key trends in each sub-segment of the global blood glucose test strips market report, along with forecasts at the global, regional and country levels from 2024-2032. Our report has categorized the market based on type, technology, distribution channel and end user.
Thick Film Electrochemical Films
Thin Film Electrochemical Films
Optical Strips
Glucose Dehydrogenase (GDH)
Glucose Oxidase (GOD)
Online
Offline
Individuals
Hospitals and Clinics
Others
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The competitive landscape of the industry has also been examined along with the profiles of the key players being 77 Elektronika Kft., Abbott Laboratories, AgaMatrix Inc., Ascensia Diabetes Care Holdings AG (PHC Holdings), B. Braun Melsungen Aktiengesellschaft, Bioland Technology Ltd., Bionime Corporation, BTNX Inc., Microlife Corporation (Midas Company Limited), Norditalia Group S.R.L., Rossmax International Ltd. and Unistrip Technologies LLC.